Perfluorohexyloctane

全氟己基辛烷

Report date: 2025/07/22 15:51:33
NME

Base Information

Drug NamePerfluorohexyloctane
Drug Alias NamePerfluorohexyloctane ophthalmic solutionPerfluorohexyloctane eye dropsNovaTearsMieboHeng Qin +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid modulators
TargetsLipid
Therapy Area/IndicationsDry Eye SyndromesMeibomian Gland DysfunctionXerophthalmia
Global Approved IndicationsDry Eye SyndromesXerophthalmia
Approved Indications in ChinaXerophthalmia
Original Approved Country/TerritoryUnited States
Original Approved Date2023/05/18
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovaliq Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesBausch & Lomb IncorporatedChengdu Suncadia Medicine Co LtdJiangsu Hengrui Medicine Co Ltd +[4] 
Inactive CompaniesEvenus Pharmaceutical Laboratories IncAlliance Medical Products IncNovaliq Gmbh
Active IndicationsDry Eye SyndromesMeibomian Gland DysfunctionXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A